ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,051.71
0.48%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vitae Pharmaceuticals, Inc. (MM) (VTAE)

  7. Vitae Pharmaceuticals, Inc. (MM) (VTAE) Noticias

VTAE

VITAE PHARMACEUTICALS, INC (VTAE)

Vitae Pharmaceuticals, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VTAE
FechaHoraFuenteTítuloSímboloCompañía
14/02/201717:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
04/11/201615:03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
31/10/201605:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201615:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201615:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201615:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201615:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201607:53Edgar (US Regulatory)(25-NSE)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201606:57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201606:56Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
26/09/201615:50Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
26/09/201615:37Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
23/09/201615:31PR Newswire (US)VITAE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vitae Pharmaceuticals, Inc. (VTAE) Over the Pro...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
21/09/201615:44Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/09/201614:01Business WireINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages ...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/09/201609:43Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201619:15Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourag...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201616:21PR Newswire (US)Harwood Feffer LLP Announces Investigation of Vitae Pharmaceuticals, Inc.NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201616:09Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201610:09Business WireVITAE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201608:40Dow Jones NewsAllergan to Buy Vitae Pharmaceuticals for $639 MillionNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201607:00PR Newswire (US)Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic ConditionsNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
01/09/201615:05GlobeNewswire Inc.Vitae Pharmaceuticals to Present at Wells Fargo Healthcare ConferenceNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/08/201615:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
12/08/201615:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
11/08/201606:30GlobeNewswire Inc.Vitae Pharmaceuticals to Present at Wedbush PacGrow Healthcare ConferenceNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
10/08/201615:05GlobeNewswire Inc.Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate SecretaryNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
04/08/201615:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
03/08/201615:05GlobeNewswire Inc.Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial ResultsNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
01/08/201616:30GlobeNewswire Inc.Vitae Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 3, 2016NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:VTAE

Su Consulta Reciente

TG
A3KWJW
Luminor Bank
BIT
P1ZG39
NLBNPIT1ZG39 20241220 4
TG
VWLD
Volkswagen Financial Ser...
BIT
NSCIT0011220
Netherlands
LSE
IDTK
Ishr Turkey
TSXV
HELX
Helix Applications
TG
LB2CPE
Landesbank Baden Wurttem...
TG
KB66
Letat Belge De Belgische...
AMEX
SOAR
Volato
LSE
81RB
Sandwell 2 'a'
EU
PHARM
Pharming Group NV
BIT
P1WK69
NLBNPIT1WK69 20240621 38
TSXV
POR
Portofino Resources
USOTC
ENCTD
Encanto Potash (CE)
GATE
BASEPTLETH
Base Protocol
LSE
BARE
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados